Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532330) titled 'Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo' on April 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Minia University
Condition:
Vitiligo
Intervention:
Device: Narrowband UVB Phototherapy
Drug: Topical Tacrolimus 0.1% ointment
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 1, 2025
Target Sample Size: 67
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/study/NCT07532330
Disclaimer: Curated by HT Syndicat...